• 温州市“千人计划”产业园签约仪式
  • 2017浙江省领军团队签约仪式
  • 2016山东省养老院考察项目
  • 2016蒙特利尔国际多元文化夏令营
  • 2016中国·浙江(加拿大蒙特利尔)海外高层次人才洽谈活动
  • 2016山东(蒙特利尔)旅加人才合作创业交流会
  • 蒙城生活指南,新人必备

Home » 新闻/活动 » 回国服务 » 2017浙江省领军团队签约(include English version)

2017浙江省领军团队签约(include English version)

经过10个多月多方协调、反复沟通和公开答辩,我们运营的“糖尿病基因诊断及治疗”项目与近日荣获2017年舟山市领军团队及政府投资,受到社会资本追捧与投资,圆满完成本轮投资计划。

After more than 10 months of coordination, repeated communication and public defense, we project "Diabetes Gene Diagnosis and Treatment" recently won the 2017 leader team in Zhoushan City, gained the government investment and is sought after by social capitals. Thus, we successfully complete the current round of investment plan.

浙江麦大基因科技有限公司注册资本1000万,营业面积超过600平米。公司首席科学家康斯坦汀教授,是加拿大皇家科学院与加拿大医学科学院两院院士,加拿大麦吉尔大学人类遗传学和儿科终生正教授,麦吉尔大学儿童健康与人类发育项目首席科学家。

Zhejiang Maida gene Technology Limited Company, has a registered capital of 10 million, the business area of more than 600 square meters. Professor Polychronakosas the chief scientist of our company, is the academician from Canadian Royal Society in both Academy of Sciences and Academy of Medical Sciences. He is also a professor in department of Human Genetics and Pediatrics and the top scientist of the Child Health and Human Development program in McGill University.

作为国际糖尿病遗传学领军人物,康斯坦汀教授主导了加、英、法14家研究机构开展的人类首次“II型糖尿病易感基因全基因组扫描”和“I型糖尿次基因组关联”重大项目,其成果被国际著名媒体广泛报道,如纽约时报、美国新闻周刊、英国每日电讯、加拿大国家电视台等,评为“影响人类健康”的人类遗传学革命先行者。

As a leader in the international diabetes genetics, Professor Polychronakos led the first major human genome-wide sequencing for type II diabetes mellitus susceptibility genes and the genome association study of type I diabetes mellitus, which was carried out by 14 research institutions from Canada, England and France. The results have been widely reported by internationally renowned media, such as the New York Times, American Newsweek, British Daily Telegraph, the Canadian national television etc. and he was hence evaluated as the pioneer of human genetics revolution that greatly influence human health.

团队组成还有资深的项目运营与市场专家,清华大学与麦基尔大学博士组成的技术团队。团队在国际最著名的《science》、《nature》及《nature》子刊上发表科研论文20余篇,关键技术获得5项美国专利。

The team has senior experts in project operation&marketing and Ph.Ds from Tsinghua University and the McGill University as technical team. The team has published more than 20 scientific papers in the top journals such as "science", "nature" and "nature genetics" , the key techniques also packed for five patents from US.

目前我国有糖尿病患者数量1.14亿,发病率由80年代0.67% 上至2016年11.6%,潜在糖尿病患者超过1亿人。团队专注开发糖尿病基因诊断技术及分析系统,目前我们的技术已经在多家医院开展临床应用或者合作,如安徽医科大学附属安徽省医院、复旦大学中山医院、复旦大学国际人类基因组变异与复杂基因组、上海交通大学上海儿童医院、杭州中医院、徐州儿童医院、徐州市妇幼保健院、南京医科大学等。

At present, the number of patients with diabetes in China is 114 million, the incidence rate has increased from 0.80% in 1980s to 11.6% in 2016, plus more than 100 million people with potential diabetes. The team focus on the development of genetic diagnosis technology and systematic a analysis in diabetes. Our technology has been generalized in a number of hospitals and carried out extensive cooperation, such as Anhui Medical University Affiliated Hospital , Fudan University Zhongshan Hospital, the international human genome variation and complex genome study of Fudan University, Shanghai Jiaotong University affiliated Shanghai Children's Hospital, Hangzhou Traditional Chinese Medicine Hospital, Xuzhou Children's Hospital, Xuzhou Maternal and Child Health Hospital, Nanjing Medical University etc.

项目签约活动于2017年5月26日在加拿大麦吉尔大学医学中心举行。浙江省人力资源和社会保障厅厅长王文序女士、浙江省外国专家局局长历勇先生出席项目签约活动并讲话,加拿大、浙江省、舟山市20余人出席活动。

The project signing ceremony was held at McGill University Health Center in Canada on May 26, 2017. Ms. Wang Wenxu, Director of Human Resources and Social Security Department of Zhejiang Province, Mr. Li Yong, Director of Zhejiang Provincial Foreign Experts Bureau attended the project signing activities and delivered speeches. More than 20 people from Canada, Zhejiang Province and Zhoushan City have attended the event.

王文序厅长详细询问了公司的发展战略与未来规划,对公司先进的发展理念、国际一流的基因诊疗技术给予高度评价,鼓励公司充分结合市场决定性作用和政府政策的指导作用,早日将糖尿病基因诊断技术进行推广,造福人类。

Wang Wenzhang asked in detail about the company development strategy and the future plan, gave a high evaluation on the company's advanced development concept and world-class gene diagnosis &treatment technology , encourage the company to fully combine the market decisive role and government policy guidance, generalize the diabetes genetic diagnostic technology as soon as possible to promote the benefit of mankind.

会上高端投资者表示浓厚兴趣,希望通过深度合作,把公司建成“十亿级”甚至是“百亿级”平台。

In the meeting, top investor expressed great interests in this project, hope that through cooperation, the company can built a platform with "billion" or even " hundred billions" grade in the future."

欢迎各大医院、医学院积极关注,前来公司参观、洽谈业务与技术合作!未来我们将在公司建立博士后工作站,欢迎各位医学人才前去创新、创业。

Welcomed the major hospitals, medical schools to actively concern about and visit the company, open business negotiations and technical cooperation! In the future we will set up post-doctoral workstations in the company, welcome medical talents to join our company and start innovation and entrepreneurship.

蒙特利尔中国学者联谊会将继续保持低调、务实、开放的态度,在有望实现关键技术革新与文化创新领域,推出一系列重点项目,并提供子女就学、人才房供给等方面的配套服务。

The Montreal Chinese Academic Association will continue to maintain a low-key, pragmatic and open attitude, expected to launch a series of key projects in the field of key technological innovation and cultural innovation and provide children schooling help, talent accommodation and other aspects of supporting services.

♦PDF新闻稿 (点击进入)

♦省厅报道 (点击进入)